Key Challenges within CAR T-cell Clinical Trials
Understanding how pharmaceutical companies can navigate regulatory oversight through streamlined techniques and logistical planning.
CAR T-cell therapies involve genetically modifying a patient’s T cells which requires careful oversight by regulatory agencies to maximize safety and efficacy. This in turn often leads to complex regulatory challenges. The panelists explain some of these challenges and what they do to face them.
An Evolving ‘Opinion’ Landscape: New Paths—and Synergies—for Pharma KOLs & DOLs
October 13th 2023Industry experts discuss the relationship between digital and traditional (key) opinion leaders and how companies are adjusting their strategies to harness the unique brand engagement benefits each role can provide in driving better patient outcomes.
